share_log

Xilio Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Gilead Sciences, Inc.(19.9%)

Xilio Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals

Xilio Therapeutics | SC 13G:超過5%持股股東披露文件
SEC announcement ·  04/05 16:36
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息